SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2026
INMODE LTD.
(Exact name of registrant as specified in its charter)
Tavor Building, Sha’ar Yokneam
P.O. Box 533
Yokneam 2069206 Israel
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒ Form
40-F ☐
Indicate by check mark whether the registrant
by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b)
under the Securities Exchange Act of 1934:
Yes ☐
No ☒
On July 10,
2026, InMode Ltd. (the “Company”) issued a press release regarding the receipt of an unsolicited proposal by Steel Partners
Holdings L.P.
A copy of
the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Additionally,
on July 8, 2026, the Board of Directors of the Company received a letter from M.N. Business Strategy Ltd. extending the expiration date
of its previously announced unsolicited proposal through September 15, 2026.
| Exhibit No. |
|
Description of Exhibit |
| 99.1 |
|
Press Release dated July 10, 2026 |
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
InMode Ltd. |
| |
|
| |
By: /s/ Moshik Itzkovich |
| |
Moshik Itzkovich |
|
July 10, 2026
|
Chief Financial Officer |
Exhibit 99.1
InMode Confirms
Receipt of Unsolicited Proposal
YOKNEAM, Israel – July 10, 2026 – InMode Ltd. (Nasdaq:
INMD) (the “Company”) confirmed that its Board of Directors (the “Board”) has received the unsolicited letter
and acquisition proposal from Steel Partners Holdings L.P. dated July 9, 2026.
The Special Committee comprised solely of the independent directors
of the Board (the “Special Committee”), together with its legal and financial advisors, will carefully review the proposal
consistent with its fiduciary duties.
The Special Committee remains committed to acting in the best interests
of all shareholders. The Special Committee does not intend to comment further at this time.
About InMode Ltd.
The Company is a leading global provider of innovative medical technologies.
The Company develops, manufactures and markets devices harnessing novel radiofrequency (“RF”) technology. The Company strives
to enable new emerging surgical procedures as well as improve existing treatments. The Company has leveraged its medically accepted minimally
invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology,
otolaryngology and ophthalmology. For more information about the Company and its wide array of medical technologies, visit www.inmodemd.com.
Forward-Looking Statements
This press release contains “forward-looking statements”
within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are
not historical facts. In some cases, forward-looking statements can be identified by terms such as “anticipate,” “believe,”
“could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,”
“predict,” “project,” “should,” “will,” “would” or the negative of those terms
or other comparable terminology. Forward-looking statements in this press release include, but are not limited to, statements regarding
the Proposal, the special committee’s review and evaluation of the Proposal, the potential consummation of any transaction and the
Company’s future plans, objectives, expectations and intentions. These statements involve known and unknown risks, uncertainties,
and other factors that may cause the Company’s actual results, performance or achievements to be materially different from those
expressed or implied. Such factors include, among others: uncertainties as to whether the special committee will determine that the Proposal
or any alternative transaction is in the best interests of the Company and its shareholders; the risk that the Proposal may be withdrawn
or modified; the possibility that competing offers or alternatives may or may not emerge; the risk that any transaction may not be consummated
on the terms or timeline currently contemplated, or at all; and the other risks described in the Company’s filings with the U.S.
Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement, whether as a result
of new information, future events or otherwise except as required by law.
Contacts
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
